The test also measures C-reactive protein and is currently performed on venous blood for greater accuracy.
This revolutionary solution allows healthcare professionals to offer patients a solution with no equivalent on the market and, thanks to an algorithm based on the concentration of antibodies directed against protein S, to evaluate the number of days remaining before the loss of immunity.
The persons tested will thus be able to know if they are among the 5% to 10% of individuals who do not produce antibodies. They will also be able to check whether their natural immunity level is sufficient or whether they need to plan a booster vaccination, and when.
All these questions can be answered with our new “Innova AttoBench System” and the “Innova CovDImmune Test”.